Form 4 holding
Director
Xenon Pharmaceuticals Inc.
- Security class
- Common Shares
- Shares / value
- 116,206
- Estimated value
- $1,144,629
- Report date
- 18 May 2021
- Price
- $9.85
- Ownership
- Direct
Michael R. Hayden - Director at Xenon Pharmaceuticals Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- XENE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Michael R. Hayden since 21 Oct 2025
Reported holdings for Michael R. Hayden in Xenon Pharmaceuticals Inc.
Form 4 holding
Director
Xenon Pharmaceuticals Inc.
- Security class
- Common Shares
- Shares / value
- 114,403
- Estimated value
- $1,126,870
- Report date
- 18 May 2021
- Price
- $9.85
- Ownership
- By wife
Form 4 holding
Director
Xenon Pharmaceuticals Inc.
- Security class
- Common Shares
- Shares / value
- 92,076
- Estimated value
- $906,949
- Report date
- 18 May 2021
- Price
- $9.85
- Ownership
- By Genworks Inc.
Form 4 holding
Director
Xenon Pharmaceuticals Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 10,000
- Estimated value
- Report date
- 03 Jun 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Transaction history for Michael R. Hayden in Xenon Pharmaceuticals Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.